- Pharmacogenomic approach for the identification of novel determinants of acquired resistance to oxaliplatin in colorectal cancer
Anna Martinez-Cardús et al, 2009, Molecular Cancer Therapeutics CrossRef - Chemoresistance Mechanisms in Colon Cancer: Focus on Conventional Chemotherapy
Klara Mladenić et al, 2021, Clinical Cancer Drugs CrossRef - Nuclear Translocation of SRPKs Is Associated with 5-FU and Cisplatin Sensitivity in HeLa and T24 Cells
Ioanna Sigala et al, 2021, Cells CrossRef - Serine-Arginine Protein Kinase 1 Overexpression Is Associated with Tumorigenic Imbalance in Mitogen-Activated Protein Kinase Pathways in Breast, Colonic, and Pancreatic Carcinomas
Gregory M. Hayes et al, 2007, Cancer Research CrossRef - Serine-Arginine Protein Kinase 1 (SRPK1) as a Prognostic Factor and Potential Therapeutic Target in Cancer: Current Evidence and Future Perspectives
Ilias P. Nikas et al, 2019, Cells CrossRef - Tumors Established with Cell Lines Selected for Oxaliplatin Resistance Respond to Oxaliplatin if Combined with Cetuximab
Marie Prewett et al, 2007, Clinical Cancer Research CrossRef - Redox-Mediated Mechanism of Chemoresistance in Cancer Cells
Eun-Kyung Kim et al, 2019, Antioxidants CrossRef - Good Cop, Bad Cop: The Different Roles of SRPKs
Eleni Nikolakaki et al, 2022, Frontiers in Genetics CrossRef